We are live on
!
Find out more
CASI
CASI Pharmaceuticals
CASI
CASI
Delisted
CASI was delisted on the 25th of February, 2026.
73 hedge funds and large institutions have $122M invested in CASI Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 30 increasing their positions, 17 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
105% more capital invested
Capital invested by funds: $59.6M → $122M (+$62.5M)
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
100% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 6
76% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 17
9% more funds holding
Funds holding: 67 → 73 (+6)
0.15% more ownership
Funds ownership: 3.2% → 3.34% (+0.15%)
Holders
73
Holders Change
+6
Holders Change %
+8.96%
% of All Funds
1.29%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
12
Increased
30
Reduced
17
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
CCM
Consonance Capital Management
New York
|
+$2.21M |
| 2 |
WSCM
Wellington Shields Capital Management
New York
|
+$1.41M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$889K |
| 4 |
WSC
Wellington Shields & Co
New York
|
+$724K |
| 5 |
BlackRock
New York
|
+$693K |
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$1.15M |
| 2 |
Millennium Management
New York
|
-$1.11M |
| 3 |
IC
Ikarian Capital
Dallas,
Texas
|
-$591K |
| 4 |
Goldman Sachs
New York
|
-$320K |
| 5 |
Russell Investments Group
London,
United Kingdom
|
-$172K |
